Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

FOSCARBIDOPA\FOSLEVODOPA: Who Reports Side Effects? Age, Gender & Country Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

Gender Distribution

42.2%
Female
57.8%
Male

Age Information

The average age of patients reporting adverse events with FOSCARBIDOPA\FOSLEVODOPA is 70.4 years.

Geographic Distribution

The majority of adverse event reports for FOSCARBIDOPA\FOSLEVODOPA originate from EU.

Report Summary & Outcomes

3,161
Total Reports
3,161
As Primary/Secondary Suspect
431
Deaths Reported
1,747
Hospitalizations
32
Life-Threatening
29
Disabilities

Reporting Timeline

First adverse event report: 20200401. Most recent report: 20250925. View full timeline →

More About FOSCARBIDOPA\FOSLEVODOPA

FOSCARBIDOPA\FOSLEVODOPA Full Profile Reports by Year Drug Interactions